Dec 3, 2025

Renerva, Inc., a Center for Life Science Ventures client developing medical devices for peripheral nerve repair, has received approval from the U.S. Food and Drug Administration to launch a first-in-human clinical study of its Renerva PNM-CAP™ nerve-cap device.

Jan 9, 2020

Renerva, a medical startup that is developing an injectable gel to speed the healing of damaged nerves and creating an off-the-shelf nerve-graft product that may spare patients life-long disability, has joined Cornell’s McGovern Center life sciences business incubator.

Sep 24, 2019

NSF and NIH grants will allow Renerva to develop its second product and expand the indication for use of its revolutionary gel for healing injured nerves

Dec 14, 2018

Groundbreaking injectable gel helps injured peripheral nerves repair and regenerate

Feb 16, 2018

Renerva, LLC, is a rapidly-growing and innovative medical device company with a focus to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures.